Meloxicam

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and anti-pyretic effects. It is an oxicam closely related to piroxicam, and falls in the enolic acid group of NSAIDs. It was developed by Boehringer-Ingelheim. Meloxicam starts to relieve pain about 30–60 minutes after administration.

Uses[edit | edit source]

Side Effects[edit | edit source]

More commonly reported ones are:


More commonly reported ones in children are:


Less commonly reported ones are:


See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]